Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (59)
  • 2025 (67)

Subject

  • Drug Trafficking (458)
  • Synthetic drugs (174)
  • Arrests/Convictions - Major (138)
  • Guns/Weapons (121)
  • Fentanyl Free America (87)
  • Seizures (Drugs/Property) (79)
  • Fake Pills (74)
  • Guilty Plea (68)
  • Counterfeit Pills (60)
  • Task Forces/Task Force Officers (50)
  • Fentanyl Awareness (49)
  • Prescription Drugs (44)
  • Major Law Enforcement Operation (37)
  • Pharmaceuticals/Pharmacists/Physicians (30)
  • Money Laundering (29)
  • Take Back Day (22)
  • Overdose (20)
  • One Pill Can Kill (19)
  • Outreach/Drug Prevention (18)
  • Cartel (16)
  • OCDETF/Task Force (16)
  • Campaigns (14)
  • Other (12)
  • HIDTA (7)
  • Extraditions (6)
  • Press Conferences (6)
  • Narcoterrorism (5)
  • Prevention/Education - DEA websites GSAD, JTT etc (5)
  • Dark Web- Internet Trafficking (4)
  • Asset Forfeiture (3)
  • Critical Incident (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Terrorism (3)
  • International/Foreign Operations (2)
  • Intelligence Division - Intelligence Products (1)
  • Red Ribbon (1)
  • Diversion Division (45)
  • Gangs (14)

Drug Name

  • Fentanyl (12)
  • Cocaine (6)
  • Methamphetamine (6)
  • Oxycodone (4)
  • Benzodiazepines (3)
  • Hydromorphone (3)
  • Amphetamines (2)
  • GHB (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Morphine (1)
  • Opioids (1)
  • Synthetic Opioids (1)

Field Division

  • Caribe (2)
  • Dallas (1)
  • El Paso (6)
  • Houston (2)
  • Los Angeles (3)
  • Louisville (2)
  • Miami (3)
  • New England (6)
  • New Jersey (3)
  • New York (7)
  • Omaha (4)
  • Rocky Mountain (2)
  • San Francisco (5)
  • Seattle (3)
  • Sede (4)
  • St. Louis (5)
  • Washington, DC (1)
Clear All Results
View Archived Press Releases
59 Results - Showing 1 to 10
PRESS RELEASE

Orlando Pharmacy and Pharmacist Agree to Pay $50,000 to Settle Controlled Substances Act Violations

Orlando, FL – Plaza Pharmacy, LLC and Paul Ezeobinwa have agreed to pay the United States $50,000 to resolve allegations that they violated the Controlled Substances Act by improperly distributing schedule V drugs and committing multiple recordkeeping violations. U.S. Attorney Gregory W. Kehoe made the announcement. “Our Diversion investigators will...
PRESS RELEASE

Health Care Fraud Unit Secures Result in Landmark Case Targeting Executives of Fraudulent Mental Health Technology Company That Distributed over 37 Million Pills of Adderall

San Francisco – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA San Francisco Division Special Agent in Charge Bob Beris, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Two Seattle Area Men Charged with String of Pharmacy Burglaries Throughout the Puget Sound Region

SEATTLE – Two men have been charged in a 24-count indictment following the investigation of a string of pharmacy burglaries that stretched from Kirkland, Washington, to Chehalis, Washington. Koumssa Wakgira, 44, of Seattle and Juston Young, 42, of Renton, Washington, are charged in an indictment alleging conspiracy to commit burglaries...
PRESS RELEASE

Founder/CEO and Clinical President of Digital Health Company Sentenced for $90 Million Scheme to Distribute over 37 Million Pills of Adderall

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...
PRESS RELEASE

Digital Health Company Founder/CEO & Clinical President Sentenced in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) Administrator Terrance Cole, DEA Northeast Associate Chief of Operations Frank Tarentino, DEA New York Enforcement Division Special Agent in Charge Farhana Islam, DEA San Francisco Division Special Agent in Charge Bob Beris, along with our law enforcement partners Homeland Security Investigations...
PRESS RELEASE

Alabama Man Admits Aiding Missouri Pharmacy Burglary that Netted 16,800 Pills

CAPE GIRARDEAU – An Alabama man has admitted involvement in the burglary of a Kennett, Missouri pharmacy last year and the theft of 16,800 pills, U.S. Attorney Thomas C. Albus announced Monday. Cornelius Cardez Bray, 31, of Birmingham, pleaded guilty Thursday to one count of intent to steal a controlled...
PRESS RELEASE

Former Albuquerque Dentist Ordered to Pay $320,000 for Violating Controlled Substances and False Claims Acts

ALBUQUERQUE – The DEA and the U.S. Attorney's Office announced today that a federal court has entered a $320,000.00 judgment against a former Albuquerque dentist to resolve allegations that he violated the Controlled Substances Act (CSA) by unlawfully issuing prescriptions after his professional licenses were revoked or expired. William C...
PRESS RELEASE

DEA and United Against Fentanyl Host Walk For Lives on July 11

MINNEAPOLIS – The U.S. Drug Enforcement Administration (DEA) and United Against Fentanyl (UAF) will host Walk for Lives Saturday, July 11, at more than 100 locations nationwide, including a family-led event in Winona, Minnesota. This national partnership with UAF is in support of DEA’s Fentanyl Free America initiative. Walk for...
PRESS RELEASE

Members and Associates of Two Minnesota Drug Trafficking Organizations Indicted and Arrested

MINNEAPOLIS – United States Attorney Daniel N. Rosen announced today the unsealing of an indictment and superseding indictment charging members and associates of two Minnesota-based drug trafficking organizations with conspiracy to distribute cocaine and fentanyl, firearms offenses, possession with intent to distribute controlled substances, and causing death through use of...
PRESS RELEASE

Warren County Physician and Nurse Practitioner Barred from DEA Registration for 20 Years For Prescribing Opioids Unlawfully

ALBANY, NEW YORK – Dr. Douglas Cline and nurse practitioner Laurie McKenna have agreed to pay $500,000 to resolve civil actions brought by the United States involving unlawful opioid prescribing practices and a fraudulent conveyance action against Dr. Cline, announced Drug Enforcement Administration New York Enforcement Division, Special Agent in...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster